Lobular Breast Cancer
An All-Round Multidisciplinary Overview
- 1st Edition - March 1, 2027
- Latest edition
- Editors: GIovanni Corso, Mark Robson
- Language: English
Lobular Breast Cancer: An All-Round Multidisciplinary Overview is a comprehensive academic resource that addresses the complex biology, diagnosis, and treatment of invasive lobula… Read more
Description
Description
Lobular Breast Cancer: An All-Round Multidisciplinary Overview is a comprehensive academic resource that addresses the complex biology, diagnosis, and treatment of invasive lobular breast cancer. This book synthesizes current research and clinical practices, offering an integrated perspective from leading international experts. It covers key topics such as genetics, pathology, imaging, surgical approaches, and systemic therapies, emphasizing recent advances and future directions. The content is organized into clearly delineated sections, including epidemiology, molecular biology, imaging techniques, and therapeutic strategies, with dedicated chapters on emerging technologies like artificial intelligence. The multidisciplinary approach ensures that clinicians and researchers gain a thorough understanding of lobular breast cancer’s unique features, diagnostic challenges, and tailored treatment options, fostering evidence-based decision-making. This book benefits its academic audience by providing up-to-date, evidence-based insights, practical guidance for clinical management, and a foundation for future research. It supports professionals in staying current with evolving standards, improving patient outcomes, and advancing scientific knowledge in this specialized field.
Key features
Key features
- Presents an integrated multidisciplinary approach, combining insights from genetics, pathology, imaging, and therapy
- Incorporates the latest research, technological advancements, and future perspectives, including artificial intelligence
- Features contributions from leading international experts, providing a global and diverse perspective
Readership
Readership
Academic and clinical researchers, specialists in breast cancer, oncologists, surgeons, radiologists, and molecular biologists
Table of contents
Table of contents
1. Introduction
2. Epidemiology
3. Genetics
4. Pathology
5. Molecular Biology
6. Imaging Techniques
7. Artificial Intelligence in Imaging
8. Surgical Management
9. Axillary Management
10. Risk-Reducing Surgery
11. Neoadjuvant Therapy
12. Adjuvant Therapy
13. Radiotherapy
14. Metastatic Disease
15. Future Directions
2. Epidemiology
3. Genetics
4. Pathology
5. Molecular Biology
6. Imaging Techniques
7. Artificial Intelligence in Imaging
8. Surgical Management
9. Axillary Management
10. Risk-Reducing Surgery
11. Neoadjuvant Therapy
12. Adjuvant Therapy
13. Radiotherapy
14. Metastatic Disease
15. Future Directions
Product details
Product details
- Edition: 1
- Latest edition
- Published: March 1, 2027
- Language: English
About the editors
About the editors
GC
GIovanni Corso
Giovanni Corso, MD, PhD, is a senior researcher at the University of Milan and a breast surgeon at the European Institute of Oncology in Milan. He earned his MD cum laude from the University of Siena, specialized in general surgery with honors and completed his PhD with honors in Medicine and Molecular Oncology from the University of Porto. Corso is president of the European Cancer Prevention Organization and editor-in-chief of the European Journal of Cancer Prevention. He has authored over hundreds of scientific articles, edited two books , and leads several funded research projects. A recognized international speaker, he has presented at dozens of conferences and received the ASCO merit award.
Affiliations and expertise
University of Milan, italyMR
Mark Robson
Prof. Robson is a board-certified medical oncologist who specializes in the identification and management of individuals who have inherited an increased risk for cancer. He concentrates on helping men and women with cancer incorporate genetic information into their treatment plan. For those who are at increased risk, but have not been diagnosed, he works to develop a plan that will help them either prevent the development of cancer, or limit its impact if it occurs. Along the same lines, his research focus has studied the best ways to use genetic information to improve the outcomes of those with or at risk for hereditary cancers of all types. Consistent with the goals, he pursues in his clinical genetics work, his oncology practice is weighted toward the management of young women with breast cancer, especially hereditary breast cancer. As part of that practice, he participates in the development of new treatments, such as PARP inhibitors, which may be particularly useful for this group of women. Finally, he also maintains a separate practice where he coordinates screening for women with mutations in BRCA1 or BRCA2
Affiliations and expertise
Memorial Sloan-Kettering Cancer centre, NY, USA